Scientific Background of Sildenafil Citrate
WIN-50 INTEX PHARMA is a sildenafil citrate compound designed for advanced erectile dysfunction research applications. This phosphodiesterase type 5 (PDE5) inhibitor represents a cornerstone therapeutic agent in cardiovascular and urological research. Sildenafil citrate functions through selective inhibition of cyclic GMP-specific phosphodiesterase type 5, preventing degradation of cyclic guanosine monophosphate in smooth muscle tissue. Research institutions studying vasodilation mechanisms and nitric oxide pathways frequently investigate this compound’s molecular interactions. Laboratories examining endothelial function and blood flow dynamics utilise sildenafil citrate in controlled experimental conditions.
Research Applications in Laboratory Settings
Scientists investigate WIN-50 INTEX PHARMA across multiple research domains including cardiovascular physiology, pulmonary hypertension models, and erectile dysfunction pathophysiology. Preclinical studies examine its effects on vascular smooth muscle relaxation and endothelial nitric oxide synthase activity. Research teams at Stroid UK Shop access this compound for investigating PDE5 enzyme kinetics and cyclic nucleotide signalling pathways. Academic institutions study sildenafil’s molecular mechanisms alongside other erectile dysfunction research compounds to understand comparative pharmacological profiles. Researchers also examine its potential applications beyond erectile dysfunction, including investigations into pulmonary arterial pressure regulation and exercise capacity in laboratory models. Studies frequently compare sildenafil citrate with compounds from selective androgen receptor modulator and peptide research categories to understand broader physiological interactions.
Technical Specifications
| Parameter | Value |
|---|---|
| Active Compound | Sildenafil Citrate |
| CAS Registry | 171599-83-0 |
| Molecular Formula | C₂₂H₃₀N₆O₄S·C₆H₈O₇ |
| Molecular Weight | 666.70 g/mol |
| Form | Oral tablets |
| Storage Conditions | Room temperature, dry environment |
Research Compliance Statement
WIN-50 INTEX PHARMA is manufactured exclusively for in-vitro laboratory research and experimental applications. This product is not intended for human consumption, therapeutic use, or any form of clinical application. Researchers must handle this compound according to institutional safety protocols and applicable regulations governing research chemicals. All studies should be conducted within approved laboratory facilities with appropriate safety equipment and trained personnel.
